Endoscopes (Flexible/Rigid) in North Carolina

Calla Health Foundation is a medical device company focused on improving women's access to cervical cancer prevention and screening, particularly in low-resource settings. The organization develops portable, affordable diagnostic imaging technologies and AI-driven decision support systems designed to democratize gynecological examination and cancer prevention. Their product suite includes the Pocket Colposcope (a portable, low-cost video colposcope for cervical tissue examination), the Callascope (a speculum-free cervical imaging device enabling self-screening or provider-assisted insertion), and CARE (an AI algorithm for cervical pre-cancer risk assessment). The company's innovations enable midwives and community health workers to perform point-of-care screening and "see-and-treat" management paradigms without requiring traditional hospital infrastructure or specialized physician expertise. FDA-cleared and clinically validated in multiple low- and middle-income countries.

PhotoniCare Inc manufactures OtoSight Middle Ear Scope, a first-in-class handheld diagnostic device for objective imaging and assessment of middle ear health. The device combines true-color video otoscopy with proprietary middle ear scanning technology to detect the presence, type, and density of middle ear fluid (effusion), achieving 90.6% accuracy in assessment. OtoSight addresses a critical clinical gap in otologic diagnosis by providing objective data to reduce diagnostic uncertainty, support appropriate antibiotic prescribing, and assess hearing loss and chronic ear infections in pediatric and general populations. The compact, handheld design is user-friendly for primary care, urgent care, and specialty ENT settings. A large randomized controlled trial demonstrated more accurate diagnosis and 50% reduction in antibiotic usage for pediatric ear infections. The company is ISO 13485:2016 certified for quality management in medical device manufacturing. PhotoniCare targets healthcare providers seeking to improve ear health outcomes through objective diagnostic data and reduce unnecessary antibiotic exposure.